This site uses cookies to improve user experience by collecting data. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our 隱私政策.
確認
MENU
CLOSE
language
Powerful, accessible cell therapies for patients with cancer.

We develop innovative, highly effective cell therapies for cancer that are broadly accessible for patients.
聯絡資訊
Acepodia USA
1600 Harbor Bay Parkway, Suite 140,
Alameda, CA 94502,
USA
Acepodia Taiwan
115011台北市南港區忠孝東路七段508號12樓
聯絡我們
電話: +1 (415) 366 7822 電子郵件: info@acepodiabio.com
關注我們
Copyright © 2020 Acepodia Inc.
隱私權政策 使用條款

AD2C

開發中產品
早期探索
前臨床
第I期
第II期
AD2C™-Oncology
標靶 GPC3, 針對肝細胞癌之抗體雙藥複合體
詳細資訊
Preclinical ​

ACC-Oncology

開發中產品
早期探索
前臨床
第I期
第II期
ACE1831
CD20標靶、ACC-γδ2 T細胞療法
詳細資訊
Phase I ​
ACE2016
抗EGFR、ACC-γδ2 T細胞療法
詳細資訊
Preclinical ​

ACC-Autoimmune

開發中產品
早期探索
前臨床
第I期
第II期
ACE1831
ACC™-autoimmune diseases
詳細資訊
Phase I ​
We have collaborated with biopharmaceutical partners and academic institutes worldwide.
聯絡我們